Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding

A new report from the Cancer Research Institute highlights the U.S. and China as cell therapy leaders

With so many ingredients on hand, can the oncology community figure out how to sensibly and efficiently combine checkpoint inhibitors with other drugs?

The startup is developing allosteric activators to increase levels of the vital metabolic molecule coenzyme A in pantothenate kinase-associated neurodegeneration

The early peek at data from a Phase I/II study excited families, physicians, and investors 

Piramal sites on different continents have become involved in producing Theracos’s diabetes treatment

The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches

Skyhawk will receive $60 million up front to develop drug candidates that target RNA in neurological diseases

The drug company is partnering with Calibr to develop universal CAR T cells directed to different tumors via antibody switches

Researchers are working to fix genetic conditions like Gaucher disease before birth by testing experimental therapies on fetal animals

The company claims its technology will allow it to access previously undruggable targets

The company claims its technology will allow it to access previously undruggable targets

Rotch Library - NA21.V47 2019

Rotch Library - NA1347.O75 2019

Upledger, John E., 1932-

Upledger, John E., 1932- author

Gabbard, Glen O, author

Hass-Cohen, Noah

Malchiodi, Cathy A

Segal, Zindel V., 1956- author

Graves-Alcorn, Sandra, author

Barker, Philip, 1929- author